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ORIGINAL CLINICAL REPORT

A Case-Control Study of Prone Positioning
in Awake and Nonintubated Hospitalized
Coronavirus Disease 2019 Patients
OBJECTIVES: To determine the association between prone positioning
in nonintubated patients with coronavirus disease 2019 and frequency of
invasive mechanical ventilation or inhospital mortality.
DESIGN: A nested case-matched control analysis.
SETTING: Three hospital sites in Bronx, NY.
PATIENTS: Adult coronavirus disease 2019 patients admitted between
March 1, 2020, and April 1, 2020. We excluded patients with do-notintubate orders. Cases were defined by invasive mechanical ventilation or
inhospital mortality. Each case was matched with two controls based on
age, gender, admission date, and hospital length of stay greater than index
time of matched case via risk-set sampling. The presence of nonintubated
proning was identified from provider documentation.

Peter C. Nauka, MD1
Sweta Chekuri, MD2
Michael Aboodi, MD, MS3
Aluko A. Hope, MD, MS3
Michelle N. Gong, MD, MS3
Jen-Ting Chen, MD, MS3

INTERVENTION: Nonintubated proning documented prior to invasive
mechanical ventilation or inhospital mortality for cases or prior to corresponding index time for matched controls.
MEASUREMENTS AND MAIN RESULTS: We included 600
patients, 41 (6.8%) underwent nonintubated proning. Cases had
lower Spo2/Fio2 ratios prior to invasive mechanical ventilation or
inhospital mortality compared with controls (case median, 97 [interquartile range, 90–290] vs control median, 404 [interquartile range,
296–452]). Although most providers (58.5%) documented immediate
improvement in oxygenation status after initiating nonintubated proning, there was no difference in worst Spo2/Fio2 ratios before and after
nonintubated proning in both case and control (case median Spo2/Fio2
ratio difference, 3 [interquartile range, –3 to 8] vs control median
Spo2/Fio2 ratio difference, 0 [interquartile range, –3 to 50]). In the univariate analysis, patients who underwent nonintubated proning were
2.57 times more likely to require invasive mechanical ventilation or experience inhospital mortality (hazard ratio, 2.57; 95% CI, 1.17–5.64;
p = 0.02). Following adjustment for patient level differences, we found
no association between nonintubated proning and invasive mechanical
ventilation or inhospital mortality (adjusted hazard ratio, 0.92; 95% CI,
0.34–2.45; p = 0.86).
CONCLUSIONS: There was no significant association with reduced risk
of invasive mechanical ventilation or inhospital mortality after adjusting for
baseline severity of illness and oxygenation status.
KEY WORDS: coronavirus infection; hypoxia; inhospital mortality;
mechanical ventilation; prone position; respiratory failure
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P

rone positioning is a well-established recruitment maneuver that can improve oxygenation and decrease mortality in patients with
severe acute respiratory distress syndrome (ARDS)
(1–3). Patients with novel coronavirus disease 2019
(COVID-19) frequently present with profound hypoxemia (4–11).
There is evolving literature in utilizing proning in
nonintubated COVID-19 patients; however, none of
these studies have demonstrated sustained improvement in patient-centered outcomes such as decreased
risk of invasive mechanical ventilation (IMV) or
improved survival (12–17). Some studies have shown
an improvement in oxygenation, but these studies are
limited by small study populations and selection bias
of healthier patients, and demonstrate nonclinically
significant end points such as temporary improvement
of oxygenation.
We conducted a large retrospective nested casematched control study to characterize the oxygenation response in a cohort of COVID-19 patients
undergoing nonintubated proning to determine the
association of nonintubated proning with patients
who develop the composite outcome of IMV or
inhospital mortality. We hypothesized that nonintubated proning would not alter the need for IMV and
inhospital mortality.

MATERIALS AND METHODS
Study Setting and Population
This study was approved by the Institutional Review
Board (IRB) at Albert Einstein College of Medicine
(IRB 2020-11278). We performed a retrospective,
nested case-control study in a cohort of consecutive
adult (≥ 18 years old) patients admitted to three hospitals in the Montefiore Healthcare System between
March 1, 2020, and April 1, 2020, with laboratory-confirmed COVID-19 via real-time reverse polymerase
chain reaction (RT-PCR) from nasopharyngeal swabs
(Cepheid, Sunnyvale, CA; Viracor Eurofins severe
acute respiratory syndrome coronavirus 2 RT-PCR,
Lees Summit, MO; Quest Diagnostics, Seacaucus, NJ).
Patients were excluded if they had a do-not-intubate
(DNI) order during the admission, as IMV was an outcome of interest, or if they were admitted to an affiliated
hospital and did not have medical records available to
the study team.
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Matching Case and Control
We defined cases as COVID-19 patients from the
above cohort who met the end point of IMV or inhospital mortality during their hospital admission. Index
time was defined as the time after hospital admission
when the case was intubated or died, whichever came
first. Controls were patients who were alive and not on
IMV between the hospital admission date and index
time of the corresponding case for risk set sampling.
From our cohort of COVID-19 positive patients, we
matched a case with two available controls by exact
age, gender, admission date within 2 weeks of case,
and hospital length of stay greater than the duration
of time from hospital admission to the index day of
the case (18). Matching was performed with replacement; thus, controls could serve as cases for other
controls if they were intubated or died. We included
all cases that had available controls from the overall
COVID-19 cohort.
Exposure: Nonintubated Proning
We manually reviewed the medical chart to extract
timing of initiation and cessation of prone positioning from clinician or nursing documentation. Based
on risk set sampling, only nonintubated proning documented prior to IMV or inhospital mortality for cases,
or prior to corresponding index time for matched controls was included in our statistical analysis.
Data Collection
Patients were identified through electronic health record data abstraction from EPIC (Verona, WI) using
Clinical Looking Glass (Clinical Analytics, New York,
NY). Baseline demographic and clinical characteristics
including age, gender, race, ethnicity, Charlson comorbidity index, body mass index (BMI), and Sequential
Organ Failure Assessment (SOFA) score at 24 hours
were extracted. We imputed the cohort median BMI
for two cases and four controls who had missing data.
For SOFA score calculation, the neurology component
uses the Glasgow Coma Score, which was not reliably
recorded in the electronic medical record; therefore,
we assumed zero for normal value for every patient.
We calculated Pao2/Fio2 ratio for the respiratory SOFA
component from Spo2/Fio2 (S/F) ratio when arterial blood gas value was not available (19). We also
xxx 2021 • Volume 3 • Number 1
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recorded whether each patient required ICU admission, hospital and ICU lengths of stay, need for IMV,
and inhospital mortality.
To obtain a measure of each patient’s oxygenation
status, we manually extracted the worst S/F ratio prior
to IMV or inhospital death for cases, or prior to corresponding index time for matched controls. Nursing
staff routinely documents peripheral saturation and
corresponding oxygen support. We recorded the lowest S/F ratio available. We used S/F ratio, because arterial blood gas data were not available for all patients
(19–22). To determine whether nonintubated proning
improved overall oxygenation status, we separately
recorded the worst S/F ratio pre- and postinitiation
of nonintubated proning on the same calendar day
of proning initiation. We recorded whether providers documented an immediate subjective or objective
perception of oxygenation improvement (regardless
of future outcome) during initiation of nonintubated
proning.
Statistical Analysis
Continuous variables were summarized with mean
and sd if normally distributed, using median and interquartile range (IQR) for nonparametric distributions.
We performed conditional logistic regression to
determine the association of nonintubated proning
as the exposure variable on the composite-dependent
outcome of IMV or inhospital mortality. We determined a priori to adjust for potential confounders
including Charlson comorbidity index, SOFA score,
BMI, and worst S/F ratio prior to index time. BMI
was also identified given practical challenges of prone
positioning morbidly obese patients and prior reported association between obesity and mortality in
COVID-19 patients (23–27). We theorized that the
worst S/F ratio represented the oxygenation status
that would likely directly influence providers’ decisions about prone positioning. Hazard ratio (HR) and
adjusted HR with 95% CIs were used to summarize
association of nonintubated proning with the outcome of interest. We performed a sensitivity analysis
using inverse-probability-weighted treatment effect
estimators. Statistical analysis was performed using
Stata Version 16.1 (StataCorp LLC, College Station,
TX). All p < 0.05 in a two-tailed test were considered
to be statistically significant.
Critical Care Explorations

RESULTS
A total of 1,566 eligible patients with COVID-19 admitted between March 1, 2020, and April 1, 2020, were
identified (Fig. 1). Of those, 348 patients met exclusion
criteria, including 274 who had DNI status during admission and 74 who were admitted to an affiliate site and
records were not available. Of the eligible 1,218 hospitalized COVID-19 patients, we identified 200 cases with
400 available 1:2 matched controls by age, gender, time
of hospital admission, and hospital length of stay greater
than the duration of time from hospital admission to the
index day of the case. A total of 36 cases also served as
matching control for a different pair.
Cohort Characteristics
Cases had a similar proportion of male gender and age
compared to the control group (Table 1). There were
no significant differences in race, ethnicity, or site between the two groups. Cases had a higher median BMI
than controls (case median, 29.9 [IQR, 26.5–33.2] vs
control median, 29.0 [IQR, 25.6–33.2]). Overall, the
cases were sicker than the controls including: higher
Charlson comorbidity index (case median, 2 [IQR, 0–5]
vs control median, 1 [IQR, 0–4]), worse SOFA score at
24 hours from admission (case median, 4 [IQR, 1.5–7]
vs control median, 1 [IQR, 0–2]), and lower S/F ratio
prior to index time (case median, 97 [IQR, 90–290] vs
control median, 404 [IQR, 296–452]).

Figure 1. Flowsheet of eligible patients who underwent matching.
COVID-19 = coronavirus disease 2019, DNI = do-not-intubate.
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TABLE 1.

Baseline and Demographic Characteristics of Cohort
Variable

Total Cohort

Case (n = 200)

Control (n = 400)

Age (yr), mean (sd)

61.2 (13.1)

61.6 (13.0)

60.9 (13.1)

Body mass index (kg/m2), median (IQR)a

29.3 (25.8–33.9)

29.9 (26.5–35.6)

29.0 (25.6–33.2)

123 (61.5)

249 (62.3)

Male sex, n (%)

372 (62)

Ethnicity, n (%)
Spanish/Hispanic/Latino

199 (33.2)

66 (33.2)

133 (33.3)

Not Spanish/Hispanic/Latino

329 (54.8)

111 (55.5)

218 (54.5)

72 (12.0)

23 (11.6)

49 (12.3)

247 (41.2)

76 (38.0)

171 (42.8)

Other/not specified
Race, n (%)
Black/African-American
Asian

20 (3.3)

10 (5.0)

10 (2.5)

White

54 (9.0)

12 (6.0)

42 (10.5)

279 (46.5)

102 (51.0)

177 (44.2)

Moses

309 (51.5)

98 (49.0)

211 (52.8)

Wakefield

130 (21.7)

41 (20.5)

89 (22.3)

Weiler

161 (26.8)

61 (30.5)

100 (25.0)

Charlson comorbidity index, median (IQR)

2 (0–4)

2 (0–5)

1 (0–4)

Sequential Organ Failure Assessment score
in 24 hr prior to index time, median (IQR)

1 (0–4)

4 (1.5–7)

1 (0–2)

Other/not specified
Hospital campus, n (%)

Worst Spo2/Fio2 ratio prior to index time,
median (IQR)b

346 (99–443)

97 (90–290)

404 (296–452)

Highest level of respiratory support prior to index time, n (%)c
HiFlow

56 (9.4)

40 (20.5)

16 (4.0)

NRB

139 (23.4)

90 (46.2)

49 (12.2)

NC

183 (30.8)

27 (13.9)

156 (39.0)

RA

217 (36.4)

38 (19.4)

179 (44.8)

Admission C-reactive protein (< 0.8 mg/dL),
median (IQR)d

13.1 (5.7–21.2)

17.6 (8.2–29.6)

11.3 (4.7–16.8)

Admission d-dimer (0.0–0.5 ug/mL),
median (IQR)e

1.49 (0.72–3.11)

2.63 (1.36–7.76)

1.03 (0.67–2.3)
(Continued)
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TABLE 1. (Continued).

Baseline and Demographic Characteristics of Cohort
Variable

Total Cohort

Case (n = 200)

Underwent prone positioning at any
point during admission, n (%)f

164 (27.3)

84 (42.0)

Control (n = 400)

80 (20.0)

Prone positioning on RA

4 (0.7)

Prone positioning on NC

36 (6.0)

3 (1.5)

33 (8.3)

Prone positioning on NRB

55 (9.2)

19 (9.5)

36 (9.0)

Prone positioning on HiFlow

24 (4.0)

10 (5.0)

14 (3.5)

Prone positioning on MV

86 (14.3)

61 (30.5)

25 (6.3)

2 (1–6)

2 (1–6)

Length of prone positioning, d (IQR)
Time from admission to prone positioning,
hr (IQR)
Required ICU admission, n (%)

79.9 (34.7–126.2)
174 (29.0)

0 (0)

4 (1.0)

3 (1–6.5)

68.8 (21.6–111.8)
117 (58.5)

88.7 (53.7–137.8)
57 (14.3)

Hospital LOS (d), median (IQR)

7.0 (4.2–12.1)

6.7 (3.8–16.2)

7.0 (4.3–11.6)

ICU LOS (d), median (IQR)

6.4 (3.7–13.0)

6.9 (3.9–13.8)

5.8 (3.3–12.8)

290 (48.3)

200 (100)

90 (22.5)

MV

247 (41.2)

175 (88.4)

72 (18.1)

Mortality

209 (34.8)

147 (73.5)

62 (15.5)

Composite event (MV or mortality), n (%)

HiFlow = high-flow nasal cannula, IQR = interquartile range, LOS = length of stay, MV = mechanical ventilation, NC = nasal cannula,
NRB = nonrebreather mask, RA = room air.
a
Body mass index data were missing for six patients.
b
Worst Spo2/Fio2 (S/F) ratio on highest oxygen device prior to time to invasive mechanical ventilation or death for cases or index time
for matched controls. In five cases, patient was intubated shortly after arrival and preintubation S/F ratio was not available. For those
instances, first available S/F ratio was used.
c
There were five case patients who were intubated shortly after arrival and the first available S/F ratio on ventilator was used. These
patients are not reflected in percentages.
d
Admission C-reactive protein (CRP) was defined as the first available value within 48 hr of admission. There were 207 patients with
available admission CRP.
e
Admission d-dimer was defined as the first available value within 48 hr of admission. There were 206 patients with available admission
d-dimer.
f
Prone positioning could occur at any point during admission, including after mechanical ventilation initiation. Patients could undergo
prone positioning on multiple types of oxygen support.

A total of 42.0% of cases underwent prone positioning at any time, regardless of respiratory support device types during their admission, as compared with
only 20.0% of control group patients. Prone positioning after intubation was implemented on 86 subjects
(14.3%). More cases required ICU admission than the
control group (Table 1).
A total of 90 controls (22.5%) met the composite
outcome of IMV or inhospital mortality at some
Critical Care Explorations

point during admission after their case-matched
index time (Table 1). A total of 247 patients (41%)
were mechanically ventilated, including 175 cases
(88%) and 72 controls (18%). A total of 38 cases
(19.4%) were intubated urgently shortly after initial
presentation; therefore, their highest level of oxygen
support prior to intubation was room air. Median
length of stay was similar between the two groups
(Table 1).
www.ccejournal.org
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Nonintubated Proning in the Cases and
Controls
There were 41 patients who underwent nonintubated
proning prior to index time (Table 2). A higher proportion of cases underwent nonintubated proning
(case: 20 [10.0%] vs control: 21 [5.3%]). Cases underwent nonintubated proning substantially later than
controls during admission (time difference, 11.6 hr
[IQR, 12.6–40.5 hr]) (Table 2). Cases were maintained
on nonintubated proning for less time compared with
controls (time difference, 39.2 hr [IQR, 0–88.9 hr])
(Table 2). A majority of both case and control patients
required a nonrebreather mask for oxygen support
during nonintubated proning (cases: 12 [60.0%] vs
control: 14 [66.7%]) (Table 2). Prior to initiation
of nonintubated proning, S/F ratios were lower for
cases than controls (Table 2). The worst S/F ratio after

nonintubated proning was similar to the ratio prior
to nonintubated proning on the same calendar day in
both cases and controls (case: S/F ratio difference 3
[IQR, –3 to 8] and control: S/F ratio difference, 0 [IQR,
–3 to 50]) (Table 2). Furthermore, the difference in S/F
ratios before and after nonintubated proning was similar between the cases and controls (Table 2). In both
case (60.0%) and control (57.1%) groups, a majority
of providers documented perceived improvement in
patient oxygenation status after nonintubated proning.
Association Between Nonintubated Proning
and IMV or Inhospital Mortality
In our univariate analysis, patients who underwent
nonintubated proning were 2.57 times more likely to
require IMV or expire during hospitalization (HR,
2.57; 95% CI, 1.17–5.64; p = 0.02) (Table 3, and

TABLE 2.

Oxygenation Characteristics of Patients Undergoing Nonintubated Proning
Variable

Total Cohort

Nonintubated proning

41 (6.8%)

Case (n = 200)

20 (10.0%)

Control (n = 400)

21 (5.3%)

Time from admission to nonintubated proning, hr (IQR) 51.1 (23.5–79.3)

61.2 (25.9–87.3) 41.9 (18.1–74.3)

Time on nonintubated proning, hr (IQR)

19.2 (4.8–40.3)

33.8 (5.1–96.9)

72.2 (20.1–124.4)

Oxygen requirement on nonintubated proning, n (%)
High-flow nasal cannula

12 (29.3)

8 (40.0)

4 (19.0)

Nonrebreather mask

26 (63.4)

12 (60.0)

14 (66.7)

Nasal cannula

3 (7.3)

0 (0)

3 (14.3)

Worst S/F ratio prior to nonintubated proninga (IQR)

95 (93–133)

93 (91–97)

98 (95–294)

Worst S/F ratio after nonintubated proning initiation
(IQR)b

95 (92–100)

93 (89–96)

97 (95–104)

3 (–3 to 8)

0 (–3 to 50)

S/F ratio difference between pre- and
post-nonintubated proningsc (IQR)
Perception of improvementd

2 (–3 to 9)
24 (58.5)

12 (60.0)

12 (57.1)

IQR = interquartile range, S/F = Spo2/Fio2 ratio.
a
Worst S/F ratio on the same calendar day but prior to initiation of prone positioning. Worst S/F ratio on the highest level of oxygen support was used.
b
Worst S/F ratio on the same calendar day but after initiation of prone positioning. Worst S/F ratio on the highest level of oxygen support
was used.
c
p value represents change pre- and postinitiation of nonintubated proning for cases and controls individually. A positive S/F ratio indicates
improvement in oxygenation.
d
Includes any objective or subjective provider documentation of improvement in patient's oxygenation status as a direct result of prone
positioning.
6     www.ccejournal.org
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TABLE 3.

Unadjusted and Adjusted Hazard Ratios on Composite Outcome of Mechanical Ventilation
or Mortality
Association With Invasive Mechanical
Ventilation/Inhospital Mortality

Unadjusted HR

p

Adjusted HRa

p

Nonintubated proning

2.57 (1.17–5.64)

0.02

0.92 (0.34–2.45)

0.86

Body mass indexb

1.03 (1.00–1.05)

0.02

1.03 (0.99–1.07)

0.10

Charlson comorbidity index

1.14 (1.07–1.23)

< 0.001

1.06 (0.95–1.19)

0.26

Worst Spo2/Fio2 ratioc

0.92 (0.91–0.94)

< 0.001

0.92 (0.90–0.94)

< 0.001

Sequential Organ Failure
Assessment score at 24 hr

1.52 (1.40–1.66)

< 0.001

1.45 (1.28–1.65)

< 0.001

HR = hazard ratio.
a
Adjusted for body mass index, baseline Charlson comorbidity index, worst Spo2/Fio2 (S/F) ratio, and 24-hr Sequential Organ Failure
Assessment score. Individual odds ratios for each contributing to adjustment are presented below. Final model contained 572 observations. A total of 22 observations were removed due to negligible contribution to model and six observations were not included due to
missing body mass index (BMI) information.
b
BMI data were missing from six patients.
c
Odds ratio corresponds to an increase in Spo2/Fio2 ratio by 10.

Supplementary Fig. 1, http://links.lww.com/CCX/
A499). After adjustment with Charlson comorbidity
index, BMI, worst S/F ratio, and SOFA score, we
found no association between nonintubated proning
and IMV or inhospital mortality (adjusted HR, 0.92;
95% CI, 0.34–2.45; p = 0.86). We saw that for every
increase by 10 in worst S/F ratio prior to index time,
the odds of IMV or inhospital mortality decreased by
8% (adjusted HR, 0.92; 95% CI, 0.90–0.94; p < 0.001).
Inversely, with every 1-point increase in SOFA score,
the odds of IMV or inhospital mortality increased by
45% (adjusted HR, 1.45; 95% CI, 1.28–1.65; p < 0.001)
(Table 3).
In our sensitivity analysis, nonintubated proning average treatment effect was –0.03 (–0.20, 0.14) and average treatment effect on the treated was –0.9 (–0.22,
0.03). Nonintubated proning did not affect the probability of IMV or inhospital mortality.

DISCUSSION
In this large case-matched control study of COVID-19
patients, nonintubated proning was not associated with
a decrease in IMV or inhospital mortality. Prone positioning was used more frequently in COVID-19 patients
with acute hypoxemic respiratory failure than previously reported in ARDS literature (Lung Safe and Severe
Critical Care Explorations

ARDS: Generating Evidence trials) and was employed
on a wide range of respiratory support devices not limited to IMV (28–30). Although the cases were more
likely to undergo nonintubated proning, they were significantly more hypoxemic and at higher risk for clinical
deterioration compared with the controls. After adjusting for patient-level difference, nonintubated proning
was not associated with IMV or inhospital mortality.
We saw an increase in the utilization of prone positioning in patients with acute hypoxemic respiratory
failure on IMV in this cohort. The patients who underwent prone positioning while on IMV were likely in
moderate-to-severe ARDS, supported by their median
worst S/F ratio. The use of prone positioning as an adjunctive therapy is more prominent than previous large
epidemiologic reports of moderate-to-severe ARDS
patients, where the use of prone positioning ranged
from 7.0% to 11.6% with higher utilization in more
hypoxic patients (16.3% in the severe ARDS population from the Lung Safe Study) (28–30). Historically,
prone positioning was rarely used at our institution.
The COVID-19 pandemic has accelerated our adoption of this evidence-based therapy.
Prior reports on nonintubated proning have
demonstrated an immediate physiologic benefit,
including improvement in oxygen saturation, alleviation of dyspnea, and decreasing respiratory rate, but
www.ccejournal.org
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it remains unclear if this translates to improved clinical outcomes. Oxygen benefit does not appear to be
universal for all COVID-19 patients, and up to half
may desaturate after resupination (14, 16). A recent
prospective cohort study noted that addition of nonintubated proning to high-flow nasal cannula therapy
did not prevent IMV or mortality (31). Many awake
patients do not tolerate extended nonintubated proning. Nonintubated proning of 16 hours or greater has
been examined but may not be practicable with most
patients (31). About 58.5% of providers documented
immediate improvement in oxygenation, but we noted
no sustained improvement in S/F ratios following nonintubated proning. Our finding supports the notion
that transient improvement in oxygenation may not be
associated with overall improvement in patients with
acute respiratory failure at risk for IMV and inhospital
mortality.
Concerningly, the strong relationship between
worst S/F ratios, SOFA scores, and nonintubated proning suggests that providers are most likely to prone
patients at risk of clinical deterioration. This could
potentially lead to delaying the initiation of IMV in
patient at highest risk. Patients undergoing nonintubated proning have been identified to undergo a delay
to intubation (31). Numerous reports have suggested
that delaying intubation for patients with hypoxemic
respiratory failure may increase morbidity and mortality (32–35). Spontaneously breathing patients with
ARDS have a high work of breathing with significant
tidal volume, which may induce spontaneous lung injury (36, 37). Delaying intubation in patients with respiratory failure may result in worsening and persistent
hypoxemia, which is linked to increased mortality (38–
40). In contrast, several recent reports have indicated
that both hypoxic COVID-19 and nonCOVID-19
patients on high-flow nasal cannula may derive benefit or at least have no harm from delayed intubation
(41, 42). It remains unclear if delaying intubation with
nonintubated proning will improve or worsen survival
in COVID-19 ARDS.
Intubated patients with mild-to-moderate ARDS
are unlikely to benefit from prone positioning. Many
studies that included mechanically ventilated patients
with mild or moderate levels of ARDS failed to demonstrate any benefit to prone positioning (3, 43–46). The
Proning Severe ARDS Patients trial only conclusively
demonstrated a mortality benefit in severe ARDS (3).
8     www.ccejournal.org

An outcome benefit has never been proven in patients
with mild ARDS. We found that proning of nonintubated patients was not beneficial, likely due to a milder
degree of hypoxemic respiratory failure at the time of
nonintubated proning. We also noted that patients in
the case group underwent nonintubated proning approximately 20 hours later than controls and remained
on nonintubated proning for a shorter duration. It is
possible that earlier initiation may have resulted in
clinical benefit.
The diverse oxygen support modes used during nonintubated proning reflect a lack of consensus
to attempt such procedures and indicate an urgent
need for robust, randomized trials to further elucidate appropriate indications for nonintubated proning. Nonintubated proning may also limit mobility in
this subgroup of patients, which may lead to heightened venous thromboembolism risk given reports of
increased venous thromboembolism in COVID-19
(47, 48).
This case-matched control analysis had some limitations. We included a heterogeneous population with
various oxygenation requirements across various support devices, which may have limited our ability to
detect clinical improvements. We used S/F ratio to
represent the severity of hypoxemia instead of the traditional Pao2-to-Fio2 ratio, as most patients did not
have arterial blood gas values. Although many patients
underwent prone positioning at some point during
their admission, only a minority qualified as nonintubated proning. The frequency of nonintubated proning
was lower than expected, which may have limited our
power in detecting an effect of the treatment. However,
in our sensitivity analysis, we did not observe a treatment effect. As prone positioning was identified based
on subjective documentation, we could not verify patient adherence to nonintubated proning or obtain the
number of hours per day that nonintubated proning
was maintained. However, our approach likely represents an accurate real-world clinical application of
nonintubated proning as strict patient adherence to 16
hours of awake proning may not be possible. As with
all retrospective analyses, we cannot exclude the possibility of unmeasured confounders. Using incident density sampling, a case could serve as a control for another
matched pair; thus, the controls may not be completely
generalizable to the whole cohort. We accounted for
the between group correlation by conditional logistic
xxx 2021 • Volume 3 • Number 1
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regression. Adjusting for forward clinical trajectory of
patients is difficult, and we did not adjust for inflammatory laboratory markers that are known to predict
mortality in COVID-19 patients. Based on our clinical experiences, physicians are more likely to prone
position patients based on oxygenation status rather
than inflammatory markers. Institutional guidelines
suggested using nonintubated proning for COVID-19
patients with hypoxemic respiratory failure, but this
was not mandatory. The application of this maneuver
likely differed by physician preference. Strengths of our
analysis include a large sample size, robust statistical
design, and controlling for many likely confounders.
A nested case-control design was used to reduce confounding via matching and decrease influence of immortal time bias. We studied a clinically relevant end
point that improves the generalizability of our finding.

CONCLUSIONS
Prone positioning among nonintubated spontaneously breathing COVID-19 patients was not associated with the need for IMV or inhospital mortality
in our large, nested case-control cohort. Although
nonintubated proning may temporarily improve hypoxemia, physicians should not expect this maneuver
to change the course of the disease. Nonintubated
proning may be appropriate in select populations,
especially during pandemic conditions with limited
resources, but physicians should rigorously monitor
respiratory parameters since prolonged and unrecognized hypoxemia could lead to more complicated
intubations and worse outcomes in patients with
respiratory failure. Indeed, we saw that intubation
rates did not appear to be altered with nonintubated
proning. Further large-scale prospective trials are
urgently needed to further elucidate whether nonintubated proning can ameliorate mortality and IMV in
COVID-19 patients.
1 Department of Medicine, Albert Einstein College of
Medicine and Montefiore Medical Center, Internal Medicine
Residency Program, Bronx, NY.
2 Department of Medicine, Division of Hospital Medicine,
Albert Einstein College of Medicine and Montefiore Medical
Center, Bronx, NY.
3 Department of Medicine, Division of Critical Care, Montefiore
Medical Center, Albert Einstein College of Medicine, Bronx,
NY.
Critical Care Explorations

Supplemental digital content is available for this article. Direct
URL citations appear in the printed text and are provided in the
HTML and PDF versions of this article on the journal’s website
(http://journals.lww.com/ccejournal).
All authors contributed to study conception, design, data acquisition, and analysis preparation of this article.
The authors have disclosed that they do not have any potential
conflicts of interest.
For information regarding this article, E-mail: jeche@montefiore.
org

REFERENCES
1. Fan E, Del Sorbo L, Goligher EC, et al; American Thoracic
Society, European Society of Intensive Care Medicine, and
Society of Critical Care Medicine: An Official American Thoracic
Society/European Society of Intensive Care Medicine/Society
of Critical Care Medicine Clinical Practice Guideline: Mechanical
ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 195:1253–1263
2. Munshi L, Del Sorbo L, Adhikari NKJ, et al: Prone position for
acute respiratory distress syndrome. A systematic review and
meta-analysis. Ann Am Thorac Soc 2017; 14:S280–S288
3. Guérin C, Reignier J, Richard JC, et al; PROSEVA Study
Group: Prone positioning in severe acute respiratory distress
syndrome. N Engl J Med 2013; 368:2159–2168
4. Jouffroy R, Jost D, Prunet B: Prehospital pulse oximetry: A
red flag for early detection of silent hypoxemia in COVID-19
patients. Crit Care 2020; 24:313
5. Kashani KB: Hypoxia in COVID-19: Sign of severity or cause
for poor outcomes. Mayo Clin Proc 2020; 95:1094–1096
6. Wang D, Hu B, Hu C, et al: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323:1061–1069
7. Wu Z, McGoogan JM: Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from
the Chinese Center for Disease Control and Prevention. JAMA
2020; 323:1239–1242
8. Alhazzani W, Møller MH, Arabi YM, et al: Surviving sepsis campaign: Guidelines on the management of critically ill adults
with coronavirus disease 2019 (COVID-19). Intensive Care
Med 2020; 48:1–34
9. Richardson S, Hirsch JS, Narasimhan M, et al: Presenting characteristics, comorbidities, and outcomes among 5700 patients
hospitalized with COVID-19 in the New York City Area. JAMA
2020; 323:2052–2059
10. Goyal P, Choi JJ, Pinheiro LC, et al: Clinical characteristics of
Covid-19 in New York City. N Engl J Med 2020; 382:2372–2374
11. Petrilli CM, Jones SA, Yang J, et al: Factors associated with
hospital admission and critical illness among 5279 people with
coronavirus disease 2019 in New York City: Prospective cohort study. BMJ 2020; 369:m1966
www.ccejournal.org

    9

Nauka et al
12. Sartini C, Tresoldi M, Scarpellini P, et al: Respiratory parameters in patients with COVID-19 after using noninvasive ventilation in the prone position outside the intensive care unit.
JAMA 2020; 323:2338–2340
13. Damarla M, Zaeh S, Niedermeyer S, et al: Prone positioning of
nonintubated patients with COVID-19. Am J Respir Crit Care
Med 2020; 202:604–606
14. Elharrar X, Trigui Y, Dols AM, et al: Use of prone positioning in
nonintubated patients with COVID-19 and hypoxemic acute
respiratory failure. JAMA 2020; 323:2336–2338
15. Thompson AE, Ranard BL, Wei Y, et al: Prone positioning in
awake, nonintubated patients with COVID-19 hypoxemic respiratory failure. JAMA Intern Med 2020; 150:1537–1539
16. Coppo A, Bellani G, Winterton D, et al: Feasibility and physiological effects of prone positioning in non-intubated patients
with acute respiratory failure due to COVID-19 (PRONCOVID): A prospective cohort study. Lancet Respir Med 2020;
8:765–774
17. Retucci M, Aliberti S, Ceruti C, et al: Prone and lateral positioning in spontaneously breathing patients with COVID-19 pneumonia undergoing noninvasive helmet CPAP treatment. Chest
2020; 158:2431–2435
18. Greenberg RS, Daniels SR, Greenberg R, et al: Medical
Epidemiology. New York City, NY, McGraw-Hill Education,
2005
19. Pandharipande PP, Shintani AK, Hagerman HE, et al:
Derivation and validation of Spo2/Fio2 ratio to impute
for PaO2/FiO2 ratio in the respiratory component of the
Sequential Organ Failure Assessment score. Crit Care Med
2009; 37:1317–1321
20. Rice TW, Wheeler AP, Bernard GR, et al; National Institutes
of Health, National Heart, Lung, and Blood Institute ARDS
Network: Comparison of the SpO2/FiO2 ratio and the PaO2/
FiO2 ratio in patients with acute lung injury or ARDS. Chest
2007; 132:410–417
21. Kwack WG, Lee DS, Min H, et al: Evaluation of the SpO2/FiO2
ratio as a predictor of intensive care unit transfers in respiratory ward patients for whom the rapid response system has
been activated. PLoS One 2018; 13:e0201632
22. Chen W, Janz DR, Shaver CM, et al: Clinical characteristics and
outcomes are similar in ARDS diagnosed by oxygen saturation/FiO2 ratio compared with PaO2/FiO2 ratio. Chest 2015;
148:1477–1483
23. Chergui K, Choukroun G, Meyer P, et al: Prone positioning
for a morbidly obese patient with acute respiratory distress
syndrome: An opportunity to explore intrinsic positive endexpiratory pressure-lower inflexion point interdependence.
Anesthesiology 2007; 106:1237–1239

26. Hussain A, Mahawar K, Xia Z, et al: Obesity and mortality
of COVID-19. Meta-analysis. Obes Res Clin Pract 2020;
14:295–300
27. Czernichow S, Beeker N, Rives-Lange C, et al; AP-HP/
Universities/INSERM COVID-19 Research Collaboration
and AP-HP COVID CDR Initiative: Obesity doubles mortality
in patients hospitalized for severe acute respiratory syndrome
coronavirus 2 in Paris hospitals, France: A cohort study on
5,795 patients. Obesity (Silver Spring) 2020; 28:2282–2289
28. Bellani G, Laffey JG, Pham T, et al; LUNG SAFE Investigators;
ESICM Trials Group: Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome
in intensive care units in 50 countries. JAMA 2016; 315:
788–800
29. Park PK, Bartz RR, Cooter M, et al: Use of adjunctive therapy
in ARDS: Results from the severe ARDS generating evidence
(SAGE) study. Am J Respir Crit Care Med 2020; 201:A5071
30. Duggal A, Rezoagli E, Pham T, et al; LUNG SAFE Investigators
and the ESICM Trials Group: Patterns of use of adjunctive therapies in patients with early moderate to severe ARDS: Insights
from the LUNG SAFE study. Chest 2020; 157:1497–1505
31. Ferrando C, Mellado-Artigas R, Gea A, et al; COVID-19
Spanish ICU Network: Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow
nasal oxygen therapy: A multicenter, adjusted cohort study. Crit
Care 2020; 24:597
32. Kang BJ, Koh Y, Lim CM, et al: Failure of high-flow nasal
cannula therapy may delay intubation and increase mortality.
Intensive Care Med 2015; 41:623–632
33. Miraflor E, Chuang K, Miranda MA, et al: Timing is everything:
Delayed intubation is associated with increased mortality in initially stable trauma patients. J Surg Res 2011; 170:286–290
34. Delbove A, Darreau C, Hamel JF, et al: Impact of endotracheal
intubation on septic shock outcome: A post hoc analysis of the
SEPSISPAM trial. J Crit Care 2015; 30:1174–1178
35. Kangelaris KN, Ware LB, Wang CY, et al: Timing of intubation
and clinical outcomes in adults with acute respiratory distress
syndrome. Crit Care Med 2016; 44:120–129
36. Gattinoni L, Marini JJ, Busana M, et al: Spontaneous breathing, transpulmonary pressure and mathematical trickery. Ann
Intensive Care 2020; 10:88
37. Tobin MJ, Laghi F, Jubran A: Caution about early intubation
and mechanical ventilation in COVID-19. Ann Intensive Care
2020; 10:78
38. Xie J, Covassin N, Fan Z, et al: Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin Proc
2020; 95:1138–1147

24. De Jong A, Molinari N, Sebbane M, et al: Feasibility and effectiveness of prone position in morbidly obese patients with ARDS: A
case-control clinical study. Chest 2013; 143:1554–1561

39. de Jonge E, Peelen L, Keijzers PJ, et al: Association between
administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients.
Crit Care 2008; 12:R156

25. Gong MN, Bajwa EK, Thompson BT, et al: Body mass index is
associated with the development of acute respiratory distress
syndrome. Thorax 2010; 65:44–50

40. Eastwood G, Bellomo R, Bailey M, et al: Arterial oxygen tension and mortality in mechanically ventilated patients. Intensive
Care Med 2012; 38:91–98

10     www.ccejournal.org

xxx 2021 • Volume 3 • Number 1

Original Clinical Report
41. Frat JP, Thille AW, Mercat A, et al; FLORALI Study Group;
REVA Network: High-flow oxygen through nasal cannula
in acute hypoxemic respiratory failure. N Engl J Med 2015;
372:2185–2196

45. Mancebo J, Fernández R, Blanch L, et al: A multicenter
trial of prolonged prone ventilation in severe acute respiratory distress syndrome. Am J Respir Crit Care Med 2006;
173:1233–1239

42. Hernandez-Romieu AC, Adelman MW, Hockstein MA, et al:
Timing of intubation and mortality among critically ill coronavirus disease 2019 patients: A single-center cohort study. Crit
Care Med 2020; 48:e1045–e1053

46. Taccone P, Pesenti A, Latini R, et al; Prone-Supine II Study
Group: Prone positioning in patients with moderate and severe
acute respiratory distress syndrome: A randomized controlled
trial. JAMA 2009; 302:1977–1984

43. Gattinoni L, Tognoni G, Pesenti A, et al; Prone-Supine Study
Group: Effect of prone positioning on the survival of patients
with acute respiratory failure. N Engl J Med 2001; 345:568–573

47. Bilaloglu S, Aphinyanaphongs Y, Jones S, et al: Thrombosis in
hospitalized patients with COVID-19 in a New York City health
system. JAMA 2020; 324:799–801

44. Guerin C, Gaillard S, Lemasson S, et al: Effects of systematic prone positioning in hypoxemic acute respiratory failure: A
randomized controlled trial. JAMA 2004; 292:2379–2387

48. Wichmann D, Sperhake JP, Lütgehetmann M, et al: Autopsy
findings and venous thromboembolism in patients with
COVID-19. Ann Intern Med 2020; 173:268–277

Critical Care Explorations

www.ccejournal.org

    11

